EINSTEIN MEDICAL CENTER MONTGOMERY — History
CCN 390329 | 3-year financial timeline | COVID resilience: 73/100
🛡️ Public data only — no PHI permitted on this instance.
$276M
Latest Revenue (FY2022)
+5.2%
Revenue CAGR (3yr)
6.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $250M | $279M | $276M | -1.1% | +5.2% |
| Operating Expenses | $272M | $301M | $257M | -14.5% | -2.8% |
| Operating Margin | -9.1% | -7.8% | 6.9% | +187.7% | +0.0% |
| Net Income | $-23M | $-22M | $19M | +186.8% | +0.0% |
| Licensed Beds | 175 | 175 | 175 | +0.0% | +0.0% |
| Total Patient Days | 51,888 | 51,545 | 53,639 | +4.1% | +1.7% |
| Medicare Day % | 28% | 28% | 29% | +4.0% | +1.9% |
| Medicaid Day % | 6% | 7% | 5% | -19.6% | -6.4% |
COVID Impact & Recovery
Resilience Score: 73/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +10.7% ($250M → $276M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+5.2%
This Hospital
+7.6%
State Avg
Latest Margin
6.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $290M | 14.8% |
| FY2024 (proj) | $303M | 22.8% |
| FY2025 (proj) | $316M | 30.8% |